Siddharth S. Kesharwani

Dr. Siddharth S. Kesharwani

Department of Pharmaceutical Sciences, Roseman University of HealthSciences, South Jordan, UT 84095, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Journal of Controlled Release
Verified
Journal Article
Closed access
VJVikas Jain
Vikas Jain
HKHitesh Kumar
Hitesh Kumar
HAHaritha V. Anod
Haritha V. Anod
PCPallavi Chand
Pallavi Chand
NGN. Vishal Gupta
N. Vishal Gupta
Siddharth S. KesharwaniSiddharth S. Kesharwani
Siddharth S. Kesharwani

5 August 2020 in AAPS PharmSciTech
Verified
Journal Article
Closed access
PDF file
Siddharth S. KesharwaniSiddharth S. Kesharwani
Siddharth S. Kesharwani
PMPooja Mallya
Pooja Mallya
VKVadikari Arun Kumar
Vadikari Arun Kumar
VJVikas Jain
Vikas Jain
SSSwagat Sharma
Swagat Sharma
SDSurajit Dey
Surajit Dey

23 October 2020 in Medicina
Verified
Journal Article
Open access
PDF file
Siddharth S. KesharwaniSiddharth S. Kesharwani
Siddharth S. Kesharwani
JGJayarama Gunaje
Jayarama Gunaje
About 40–70% of drug molecules in the clinical development pipeline suffer from one of either low aqueous solubility, poor absorption, or extremely low bioavailability. Approximately 75% of the world population relies on traditional therapies and therefore there has been a growing interest in the utilization of natural compounds. Zerumbone is one such natural compound, classified as a sesquiterpenoid that is extracted from the essential volatile oils of rhizomes from Zingiber zerumbet. It possesses strong antitumor, antioxidant, antimicrobial, and anti-inflammatory activity. However, despite promising preclinical studies demonstrating the therapeutic utility of zerumbone, its clinical development has been limited due to its low aqueous solubility, poor absorption, or associated low bioavailability. Multiple reviews demonstrating the pharmacological effects of zerumbone for various diseases have been published. However, to our knowledge, no review demonstrates the various formulation strategies developed to overcome the biopharmaceutical challenges of zerumbone. The purpose of this review is to provide a comprehensive perspective on zerumbone as a molecule for formulation development. A section related to pharmacokinetics, toxicity, and patents of zerumbone is included. This review provides the importance of developing novel formulations of zerumbone to overcome its biopharmaceutical challenges thereby advance its potential in the treatment of various diseases.